McDermott Health Podcast Channel: Recent Episodes
McDermott Health Podcast Channel
Listen to McDermott’s Health thought leaders share their perspectives on a range of topics impacting the healthcare sector.
©2019 McDermott Will & Emery. All rights reserved. Any use of these materials including reproduction, modification, distribution or republication, without the prior written consent of McDermott is strictly prohibited. This may be considered attorney advertising. Prior results do not guarantee a similar outcome.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Farragut’s own Assistant Vice President, Holly Stokes. Holly provides an update and 2024 outlook for the No Surprises Act (NSA). They discuss the carve out, as well as the status of the committee and their recommendations. Along with this update, they share their thoughts on the NSA’s potential impact on the industry.
The Driving the Deal podcast is back for its fourth season! We're bringing you the latest topics impacting the healthcare private equity space. In this new episode, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, McDermott Partner and co-head of the Firm’s Private Equity Practice Group, are joined by Farragut Square Group’s Assistant Vice President, Holly Stokes, and Director of Research, Jackie Williams, to provide insights from the 2024 J.P. Morgan Healthcare Conference in San Francisco. Together, they discuss what people are expecting this year in the deal market, providing key takeaways and sharing their thoughts on various sector themes.
In this episode, McDermott partner Dale Van Demark sits down with Liz Rockett for her thoughts on working at the intersection of investor-driven and mission-driven healthcare investment, the role of entrepreneurs in driving healthcare innovation, what's driving the flow of investor dollars into the digital health space and more.
In this episode, McDermott partner Bernadette Broccolo sits down with Dr. Broyles for his thoughts on the measures and avenues for health system success in implementing new digital health technologies, the areas of digital health innovation driving health system digital health strategies, the importance of balancing health system innovation imperatives and enterprise risk tolerance and more.
In this episode, McDermott partner Sharon Lamb sits down with Andrew Davies for his thoughts on UK's digital health market, medical device regulation, areas for digital health opportunity, Brexit's impact on healthcare innovation and more.
In this episode, McDermott partner Marshall Jackson sits down with Michelle Davey for her thoughts on virtual care's role in strengthening health infrastructure, provider-focused telehealth solutions, driving forces behind the growth of telehealth and more.
In this episode, McDermott Digital Health partner Dale Van Demark sits down with Dr. Karen Murphy for her thoughts on how healthcare systems can make accesses easier for patients, the growing disruption and innovation in the healthcare industry, closing the digital divide and more.
Digital Health partner Dale Van Demark sits down with Dr. Chaudhry to learn how the Federation of State Medical Boards (FSMB) is advancing the interstate practice of medicine, the role of state boards in digital health adoption, the importance of prioritizing physician mental health and more.
In this episode, McDermott Digital Health Co-Chair Lisa Mazur sits down with Lee for his thoughts on key ingredients of a successful digital health solution, what he looks for in early-stage companies, top trends in digital health and more.
In this episode, McDermott Digital Health Co-Chair Stephen Bernstein discusses innovation opportunities presented by the interoperability rule, the importance of practical application in rulemaking and more.
In this episode, McDermott Digital Health partner Jennifer Geetter sits down for a candid conversation on the state of digital care in the US, the importance of data sharing for effective care and public health, and more.
The board’s executive compensation committee has traditionally been one of the most prominent of all board functions, with its focus on such interconnected responsibilities as oversight of the executive compensation process, compensation data analysis, talent recruitment and executive search. This episode is the first in a two-part discussion filled with valuable insight and the latest developments affecting compensation committees from two recognized health industry compensation and benefits experts, Tim Cotter and Ralph DeJong. Tim and Ralph will discuss such important topics as: - The current state of salary, increase budgets, incentive award levels and emerging compensation practices. - Developing retention and predictable transition strategies. - Insights into application and interpretation of the IRS “rebuttable presumption” standards. - Needed changes to highly prescriptive compensation philosophies. - Tactics for encouraging executive retention beyond traditional cash incentives.
It's the perfect time of year to take stock of the leading developments of the prior 12 months and consider what lessons they have to offer us. This valuable exercise for corporate directors can put them in a better position from which to address the looming agenda items their boards face in 2023. For directors of healthcare companies, governance trends range from the economy to the corporate social voice, ESG to mission-critical corporate risks with many stops in between. To lead this review, Michael Peregrine sits down with Charles Elson, Founding Director, Weinberg Center for Corporate Governance, Retired, Willard Shared, Corporate Governance, University of Delaware, and Executive Editor at Large, Directors & Boards. Charles offers a comprehensive review of the leading governance issues of 2022, as well as a look at what may be to come in 2023.
On this episode - the third in our new Governing Health special edition series - Ken Kaufman, Co-Founder and Managing Director of Kaufman Hall and Michael Peregrine discuss the board’s top post-pandemic governance challenges, including: > The concept of “languishing” within companies in the wake of COVID-19 > Strategic planning tactics to resume normal organization activity > The critical need to maintain a competitive advantage post COVID-19 > Maintaining growth through M&A activity given increased antitrust enforcement > Board/executive partnering to address nonprofit healthcare’s role in the ESG movement > Confronting the dramatically expanded post-pandemic board agenda
The restatement of the law of charitable non-profit organizations provides helpful and useful summaries regarding what contributors believe to be the state of the law. On this episode of the Governing Health podcast host Michael Peregrine welcomes legal scholar and policy expert Professor Jill Horwitz to help bring clarity to the restatement of the law of charitable non-profit organizations. Professor Horwitz offers key insights into the scope of this new publication regarding the topics it covers, the relevance it provides and suggestions on how to best use this research on behalf of our health system clients.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, and Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, sit down with John Jamison, Director of Healthcare Investment Banking at Cantor Fitzgerald. Together, they discuss the macroenvironment of the allergy and ENT space, commenting on what’s sparking interest in the sector and what’s in store for the next year. Additionally, they take a look at the service mix and provide thoughts on investing in the space.
We’re delighted to offer the latest episode in our popular series of podcast dialogues with Ken Kaufman, co-founder and managing director of healthcare management consulting firm Kaufman Hall. In this episode, Ken and podcast host Michael Peregrine return to the social science concept of “wicked problems”—problems that have no single, correct solution. In fact, a solution that improves one aspect of a wicked problem usually makes another aspect of the problem worse. Ken believes that the current hospital operating environment is overwhelmed by wicked problems, and during the conversation, he shares his insight on: How wicked problems impact hospital-client issues Keeping management and boards appropriately informed and engaged, including key metrics that board members must be aware of Balancing the crisis of regulation with a hospital’s need to scale Addressing and debriefing the board on post-COVID-19 strategies Managing media and political attacks on hospitals Additional Resources:
We’re delighted to offer the latest episode in our popular series of podcast dialogues with Ken Kaufman, co-founder and managing director of healthcare management consulting firm Kaufman Hall. In this episode, Ken and podcast host Michael Peregrine return to the social science concept of “wicked problems”—problems that have no single, correct solution. In fact, a solution that improves one aspect of a wicked problem usually makes another aspect of the problem worse. Ken believes that the current hospital operating environment is overwhelmed by wicked problems, and during the conversation, he shares his insight on: How wicked problems impact hospital-client issues Keeping management and boards appropriately informed and engaged, including key metrics that board members must be aware of Balancing the crisis of regulation with a hospital’s need to scale Addressing and debriefing the board on post-COVID-19 strategies Managing media and political attacks on hospitals Additional Resources:
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by his colleague, Sharon Lamb, Partner and head of the U.K. health practice at McDermott Will & Emery. Together, they debrief HPE Europe 2023, discussing their findings on investment trends and opportunities, as well as current market challenges. They also provide insight on innovative advancements, market dynamics, and forecasts for 2024.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Houlihan Lokey’s own Mark Francis, Managing Director and Global Head of its Healthcare Group. Together, they discuss the sectors expected to see an increase in deal volume and activity, a review of activity and deal flow in the last three quarters, sectors that are cooling off, the impact of digital health in the healthcare industry, and an outlook for the rest of the year and 2024.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by FSG’s own Assistant Vice President, Holly Stokes, in an insightful overview of the recently released 2024 Physician Fee Schedule (PFS) proposed rule. They shed light on the PFS’s significance and impact on providers. Holly provides a comprehensive overview of the proposed changes, including the notable 3.4% cut to the conversion factor, and presents an outlook for potential congressional intervention as well as other specialty-specific changes.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by L.A. Galyon IV, managing partner at Brentwood Capital Advisors, for the final segment of our three-part behavioral health series. Together, they have a riveting conversation on the psychiatry space, discussing today’s macro-environment and service mix. Additionally, they provide insights on current reimbursement issues and investment opportunities within the sector.
During this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by L.A. Galyon IV, managing partner at Brentwood Capital Advisors, for part two in our three-part behavioral health series. Together, they delve into the substance use disorder (SUD) space and its macro environment. They also share their thoughts on the evolving demand for relevant services in recent years and provide valuable insights on investment opportunities within the SUD sector.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Dan Beuerlein, managing director at Brentwood Capital Advisors. Embarking on a three-part behavioral health series, Brian and Dan discuss the autism space, including the macro environment for autism, as well as the service mix and evolution. They also share their thoughts on investing in the autism space.
In this episode, hosts Kristian Werling, McDermott partner and co-head of the Firm’s Private Equity Practice Group and Brian Fortune, senior managing director at Farragut Square Group, recap McDermott’s 2023 HPE Miami event. Together, they share key themes from the conference, discuss current healthcare deal market highlights and chat about various areas of interest and activity in spaces such as infusion/AICs, cardiology, ophthalmology, home care personal services, payor services, etc. Brian and Krist also share their thoughts on the timing of market activity and Silicon Valley Bank’s impact on the market.
In this episode, host Brian Fortune, senior managing director at Farragut Square Group, and Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, are joined by Brown Gibbons Lang & Company’s own John M. Tiedmann Jr., Director and senior member, and J. Kyle Brown, Managing Director and senior member of their Healthcare & Life Sciences team. They discuss the current state of the deal market and deal flow and provide insight into the most active spaces in healthcare and the macro market forces affecting opportunities this year.
In the 14th episode of Season 2: Driving the Deal, Krist Werling, McDermott Will & Emery partner and co-head of the Firm’s private equity practice, and Brian Fortune, senior managing director at Farragut Square Group, recap McDermott’s 2022 HPE New York event. Together, they share key themes from the conference and discuss current healthcare deal market highlights, including: The trends slowing down large deals while also powering activity in the low and middle market The current debt market, outlook for 2023 and potential financing opportunities A look at the activity within the pharmaceutical services space An overview of recent CMS rulemaking (e., PFS, OPPS, home health and ESRD) The future of dealmaking as we head toward a potential recession
The board’s executive compensation committee is the focus point for many of the extraordinary financial, economic and operating challenges currently facing healthcare organizations. Executive compensation increases are impacted by both an inflationary economy and significant revenue downturn. In addition, the Department of Justice has identified executive compensation as an important conduit through by which corporate compliance incentives and deterrence can be implemented. Furthermore, executive recruitment and retention amidst the “Great Resignation” remains a key compensation concern. These and similar issues have become important agenda items for the board’s executive compensation Committee. Michael Peregrine is joined by industry experts Tim Cotter and Ralph DeJong for the first in a two-part conversation about the impact of the developments on the compensation committee, including: Key topics for briefing the board’s compensation committee. Increasing communication between the compensation committee and the C-Suite. Addressing pressures felt by executive committee members. Insights from the Sullivan Cotter compensation data survey. Projections for the impact of inflation on next year’s salary increases. Expectations for future CEO salary increases and organization departures. The segmenting approach to leadership plans. Coordination with the Audit & Compliance Committee on compensation incentives
Nonprofit healthcare organizations and their governing boards are subject to the authority of the state attorney general, which has broad statutory and common law power with respect to its duty to preserve charitable assets. The attorney general is supported in this work by dedicated charity officials who work within what is normally referred to as the “charitable trust division” of the attorney general’s office. To help inform nonprofit health systems and their leaders on the role of the attorney general and its charity regulators, Michael Peregrine is joined by Leslie Friedlander, an Assistant Attorney General in the office of the Texas Attorney General. Leslie is currently the president of the National Association of State Charity Officials (NASCO), and offers a “refresher course” about state regulation of nonprofit organizations, and NASCO’s related educational role, including: An overview of the role of NASCO, its purposes, and the value of its educational materials. Charity officials’ interest in nonprofit board business practices. How state charity officials gather information that informs enforcement policies. Effective means of communication between the charitable sector and NASCO. Examples of what a state charity official might consider as “red flag activities” by a nonprofit and its board. Other divisions within the Attorney General’s office that may get involved with charitable trust decisions. NASCO’s priorities and policies for the coming year.
Corporate directorship continues relentlessly to increase in complexity. The ability of directors to fully engage with the board agenda and to be effective partners in management are two of the most critical corporate governance issues in the current environment. These are issues that implicate a level of commitment by directors to be informed, attentive, and up to speed on their duties and on the issues of importance to the organization that they serve. This commitment is made even more critical this year by the many turns of events that are impacting the agenda in many boardrooms. To learn more about how directors at leading companies are handling this increase in role complexity board communication, Kimberly Simpson, the COO of NACD (the National Association of Corporate Directors) which serves both for-profit and nonprofit directors and boards, and offers the country’s premier director certification program, joins Michael Peregrine for a conversation about the multifactorial challenges facing boards today, including: The role of directors in understanding today’s topsy turvy economic environment Where private and public company directors place inflation within other boardroom priorities ESG challenges and opportunities The important role of board refreshment Top trends from NACD’s public and private company surveys Updates on NACD Directorship Certification®
In Season 2, Episode 13 of Driving the Deal, Farragut Square Group’s (FSG) Brian Fortune and Jackie Williams are joined by FSG’s Assistant Vice President Hope Amsterdam. In this episode, they discuss recent reimbursement-related developments for Medicare and Medicaid on the state level, as well as: Major Medicare and Medicaid investments made by states during the most recent budget cycle Positive July rulemaking for post-acute care and inpatient psychology Reimbursement adjustments for hospice, inpatient rehabilitation facilities and inpatient psychology Case-mix adjustments to the positive skilled nursing facility (SNF) patient-driven payment model Centers for Medicare & Medicaid Services’ (CMS) final rule for SNFs Home Health proposed "Temporary” and “Permanent” adjustments
In the 12th episode of Season 2: Driving the Deal, Farragut Square Group’s (FSG) Brian Fortune and Jackie Williams are joined by Holly Stokes, senior research associate at FSG, for a discussion on the future of physician practice management (PPM). Specifically, the trio delves into the regulatory actions that occurred within the PPM sector this past year as we head into end-of-year legislation and rulemaking, as well as the anticipated pressures for market participants in 2023 and 2024. In this episode, they also talk about: Regulatory changes for PPM companies Proposed cuts to the Physician Fee Schedule Implications of the ruling in Dobbs v. Jackson Women’s Health Organization on the fertility and OBGYN sectors Drug pricing provisions in the Inflation Reduction Act of 2022 Future implementation of the No Surprises Act and qualifying payment amount calculation
In the 10th episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Mark Francis, managing director at Houlihan Lokey and head of its Healthcare Group, as they summarize the end of Q2 for the healthcare industry. Together, they discuss the following: Healthcare sectors poised to see an increase in deal volume and activity A review of activity and deal flow in Q1 and Q2 Sectors that are cooling off post-Q1 and Q2 The impact of digital health on the healthcare industry Sectors heading into distress territory Q3 insights
To highlight the important connections between financial risk management, the credit rating process and effective governance, Michael Peregrine welcomes Lisa Goldstein, Senior Vice President at Kauffman Hall and a nationally recognized analyst, speaker, writer and expert on nonprofit healthcare, for a conversation exploring: The responsibilities of a strong finance committee The value of subject matter expertise within the finance committee Key metrics that rating agencies use to evaluate governance Insights from high-performing healthcare system boards The role of covenant management in repayment performance Lessons learned from the pandemic, including credit-related crisis management ESG issues for nonprofit healthcare
In the newest episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Ashley Fischer, McDermott health antitrust partner. Together, they discuss the following concerning healthcare antitrust in the Biden administration: The Federal Trade Commission’s (FTC) signaled interest in the effect of private equity on competition How the FTC views hospital consolidation Major cases in the physician market and subsequent enforcement activity Tips for investing with new scrutiny Labor market competition and recent significant cases
In episode 8 of Season 2: Driving the Deal, Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by Elle Kalisz, a research analyst at FSG, and Swatee Survee, CEO and founder of Litesprite. Together, they explore all things digital technology, including: What is a Digital Therapeutic? What makes a Digital Therapeutic different from traditional digital health tools? The intersection of digital self-help tools and mobile gaming. Provider, payor and employer uptake/participation. Insights for investors interested in the digital technology space.
July 30, 2022, marks the 20th anniversary of the Sarbanes Oxley Act, one of the most consequential pieces of federal financial regulation ever enacted into law. It serves as the foundation for many of the guidelines and principles that are now considered routine by boards and their audit, compensation and finance committees. It’s difficult to overstate the continuing impact of Sarbanes on corporate governance. Thus, given the passage of time there is value in board members refreshing their familiarity with the Sarbanes history, in order to better appreciate its influence. To help underscore the Sarbanes legacy, Michael Peregrine welcomes back Scott Steffens, well-known audit partner in Grant Thornton’s national nonprofit and educational practice. In their conversation, Scott and Michael review the circumstances that led to Sarbanes’s enactment, and how auditor, management and audit committee interactions have changed over the last 20 years, particularly in the nonprofit and healthcare sectors, including: - The role and function of the Audit Committee - The continuing importance of independent directors in Committee membership - The frequency and length of Audit Committee meetings - Rotation of the lead audit partner - Preserving auditor independence - Internal consideration of issues raised in “Management Letter” - Related party disclosures
In Season 2, Episode 7 of Driving the Deal, Krist Werling, McDermott partner and co-head of the Firm’s Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Brian Stimson, a partner in McDermott’s Healthcare Practice Group and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services. Together they discuss current litigation surrounding the impending future of the No Surprises Act, as well as: -The specialties most impacted by the legislation and subsequent litigation - An overview of the No Surprises Act and current litigation surrounding it -The Act’s impact on providers -Next steps for future litigation
Recent events have made it clear that the board won’t be retreating any time soon from a high level of engagement with management on patient care and safety matters, but what is the appropriate level of board engagement? To answer that question, welcomes back , president of Orlikoff & Associates, Inc., and , MWE partner, leader of McDermott health advisory on patient care and safety and accreditation issues, and author of the recent client memo series on vaccination mandates and workplace safety developments, for an update on where we stand two years into the COVID-19 pandemic, including: Implications and expectations from hospital boards regarding current COVID-19 rates. The regulatory authorities response to competing pandemic-related pressures. Board guidance for addressing financial concerns in light of a stealth surge The governance challenges associated with growing supply chain issues. Universal truths following the pandemic that are valuable to healthcare boards. Defining purpose and the role of hospitals in leading healthcare issues. Additional Resources:
In the sixth episode of Season 2: Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Brian Stimson, Healthcare Partner at McDermott Will and Emery and former Acting General Counsel & Principal Deputy General Counsel for US Department of Health and Human Services, discuss the unwinding of the COVID-19 Public Health Emergency (PHE). They discuss the following topics: Expected end of the COVID-19 PHE Conclusion and future of telehealth flexibilities Medicaid eligibility issues associated with the end of the PHE Remaining PREP Act Declarations Next moves for CMS and other agencies
The key topics that should be receiving board attention in the near term have less to do with traditional operational matters, and more to do with social and economic issues of concern to the workforce and the mission. To bring understanding to these key concerns, we turn to our quarterly conversation with Ken Kaufman, Co-Founder and Managing Director of Kaufman Hall. Ken has been visiting with clients and other leaders of the healthcare industry and has also been busy with his popular blog, addressing pressing subjects ranging from inflation to artificial intelligence. Ken has returned to our podcast today to share his insights on topics that include: Social justice board initiatives that have developed in the wake of the George Floyd murder. The impact of individual actions regarding equality at the CEO level. Addressing current workforce culture and employee retention concerns. The impact of rising inflation rates on hospitals and health systems. Realities and expectations of today’s board members. Forward-thinking advice for board members and directors. Additional Resources:
In the fifth episode of Season 2: Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, and guest co-host Holly Stokes, Senior Associate at Farragut Square Group, are joined by Justin Santa Cruz, Chief Development Officer at US Eye, an integrated, multi-specialty eye care platform. Recording live at McDermott’s annual Physician Practice Management & ASC Symposium in Nashville, Brian, Holly and Justin discussed: Operational and demand changes US Eye made in response to COVID-19 Current challenges and opportunities in the ophthalmology space Key features of ophthalmology assets for acquisitions and expansion The increasing role of private equity in ophthalmology The outlook for M&A activity in ophthalmology for 2022
The social and economic phenomenon known as “the Great Resignation” is now impacting hospital and healthcare CEOs. This, according to important new analysis from the well-known outplacement and search firm Challenger Gray & Christmas. To provide boards with a perspective on rising incidents of CEO resignation and their impact on healthcare organizations, we turn to our quarterly conversation with John Challenger and on the CEO employment status. In this episode, host Michael Peregrine and John Challenger offer members of the board executive search, finance and HR committees an important update regarding CEO resignation trends, as well as an interpretation of economic data as it may impact health systems. Insights include: Findings from the Challenger, Gray & Christmas report and their implications for the board’s search and succession process. Recommendations to boards regarding CEO monitoring and succession planning. How cultural changes and concerns are prompting the increase of CEO resignation. Key warning signs of CEO fatigue. Observations regarding leading economic indicators in the second quarter; e.g. inflation, unemployment rate and job participation statistics. Final words of caution for board consideration. Additional Resources:
In the fourth episode of Season 2: Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, and guest co-host Jackie Williams, Head of Research at Farragut Square Group, are joined by Holly Stokes, Senior Associate at Farragut Square Group, live at McDermott’s annual Physician Practice Management & ASC Symposium in Nashville. Brian, Jackie and Holly discuss: The stability and continued interest in gastroenterology and ophthalmology Specialties emerging as the next frontier for PPMs Challenges and special considerations for cardiology and ambulatory infusion The current macro pressures for PPMs including budget neutrality, clinical labor, sequester and pay-go
Part two of this series addresses key issues facing the board’s compensation committee when evaluating executive compensation, data analysis, recruitment and retention, and executive search matters. This episode features industry leaders, Tim Cotter and Ralph DeJong, as they offer extraordinary insight on emerging priorities and trends impacting the compensation committees, including: The evolution of annual and long-term incentive plans. The retention effect of executive pay and benefit programs. The continued relevance of for-profit compatibility data. Handling executive and director co-investment arrangements. Approaching CEO compensation earned from outside board service.
The board’s executive compensation committee has traditionally been one of the most prominent of all board functions, with its focus on such interconnected responsibilities as oversight of the executive compensation process, compensation data analysis, talent recruitment and executive search. This episode is the first in a two-part discussion filled with valuable insight and the latest developments affecting compensation committees from two recognized health industry compensation and benefits experts, and . Tim and Ralph will discuss such important topics as: The current state of salary, increase budgets, incentive award levels and emerging compensation practices. Developing retention and predictable transition strategies. Insights into application and interpretation of the IRS “rebuttable presumption” standards. Needed changes to highly prescriptive compensation philosophies. Tactics for encouraging executive retention beyond traditional cash incentives.
In the third episode of Season 2: Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Mark Francis, Head of Healthcare and Managing Director at Houlihan Lokey, live at McDermott’s annual Health Private Equity event in Miami. They discuss the following topics: Healthcare sectors poised to see an increase in deal volume and activity Convergence of sectors creating new services in the next five years Future of orthopedic deals and changing sector activity “Transformative” deals and entering the innovative side of healthcare Value-based care and its impact on the market
On this episode of In the Trenches, McDermott partner and program host Brian Stimson continues his conversation with and of Epsilon Consulting and , Vice President of to discuss their thoughts on the Cares Act and Provider Relief Funds, including: Pain points for providers on PRF compliance and enforcement Proactive steps to mitigate PRF fund risk regarding balance billing A simple and conservative approach to the loss of revenue methodology Risks and considerations presented with “double-dipping” Best practices for providers to mitigate risk in 2022 Points when engaging with HRSA Additional Resources:
On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with and of Epsilon Life Sciences and , Vice President of to review the history of the PRF, the big pain points for PRF recipients, and what to do about them, including: How HHS stood up the PRF at the height of the pandemic How different PRF recipients operationalized the program requirements What providers can still do if HHS denied some or all the PRF funds they sought How the recent history informs current PRF reporting and enforcement risks The biggest reporting and compliance pain points for PRF recipients What PRF recipients should expect, and do next Additional Resources:
In this second episode of Season 2 of Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Frank Martin, Head of Commercial Care at Farragut Square Group and a leader in commercial managed care. The topics discussed include: - The dominant trends in the commercial care market heading into 2022 - The state of beneficiary enrollment in Medicare Advantage - Managed care payor interaction in the Behavioral Health space and Medicaid - Proactive revisions to change of control specifications in deal contracts
COVID-19 concerns continue to dominate the boardroom agenda, from patient safety and access to care to understaffing and the concerns surrounding healthcare workers and management fatigue. welcomes back , president of Orlikoff & Associates, Inc., for an update on where we stand two years into the COVID-19 pandemic, including: Lessons that boards need to have learned two years into the pandemic. A realistic perspective on the transition from pandemic to endemic. The implications of operating a hospital or healthcare system at the forefront of COVID-19. Risks associated with government intervention in the healthcare standard of care crisis. Key issues facing board leadership at the beginning of 2022. Additional Resources:
In this episode of Driving the Deal, Krist Werling, McDermott Partner and Co-Head of Private Equity, and Brian Fortune, Senior Managing Director at Farragut Square Group, are joined by Holly Stokes, Senior Analyst at Farragut Square Group and veteran of numerous healthcare deals across the provider continuum. The topics they discuss include: The state of the deal market in 2022 Deal questions surrounding PPMs Overview changes impacting the post-acute and home health sectors Changing activity in the behavioral sectors with a focus on SUDS Increased deal activity in the digital health space
On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with , co-chair of McDermott’s Supreme Court appellate practice, and , President of the National Association for Homecare and Hospice, to discuss their thoughts on the relationship between litigation and healthcare policy, including: Insights from Michael's and Bill’s careers on the APA litigation side of health law How to engage with agencies to increase the likelihood of obtaining good policy outcomes without resorting to litigation Similarities between the rulemaking process and trial court proceedings and the importance of appellate strategy to both Engagement with the Hill to help drive the outcome of the rulemaking process The challenges of litigation and parallel rulemaking Key cases to follow in 2022 Additional Resources:
As the most recent economic news indicates a slowdown in hiring coupled with a continuing decline in the unemployment rate and an increasingly tight job market, there seems to be a lot of confusion to clear up. Mix this all with a 7% unemployment rate and The Great Resignation, and we could all benefit from a little guidance. This week, welcomes back , for his perspective on economic trends and the messages he derives from them, what it means for board oversight and what he really thinks about The Great Resignation. John and Michael also discuss: Who are the people leaving their jobs in the Great Resignation and why are they leaving? How can recruiters target each group leaving during the Great Resignation? What is the ripple effect of offering promotions as an attraction for retention? What extent does the normalization of the pandemic affect the issues of retention and a tight labor market? Additional Resources:
As the US comes out of the dreaded fourth wave of the COVID-19 pandemic, the healthcare industry is facing one of the biggest unintended consequences of the pandemic — “tired of being your hero” syndrome. With healthcare professionals leaving the industry in the name of burnout, stress, safety, moral harm, and even personal freedom, a passive governance approach to caring for the caregivers simply won’t work anymore. To review what board members need to do to be engaged in the face of these issues, as well as their governance implications, is joined by , President and CEO of leading healthcare strategic communications firm, Jarrard Phillips Cate & Hancock, and , Vice President and Co-Chief Legal Officer and Chief Officer team member for Health and Safety at Hackensack Meridian Health, one of the largest not-for-profit hospital systems in New Jersey. Together, they discuss how board leaders can address the growing crisis in the healthcare provider community, including: Clearing up the moral and safety concerns leading to burnout Recovering from the breakdown in trust between healthcare clinicians and administration Ways for hospitals and health systems to retain and attract wavering staff The future of managing the healthcare workforce as a result of the pandemic Additional Resources:
Lyn Amor Macaraeg is the Vice President of Legal Services and Corporate Secretary with agilon health, and is a longtime colleague and friend of program host Brian Stimson. Lyn began her career at the California Department of Managed Health Care (DMHC), and has over 15 years of legal experience, including serving as in-house counsel to leading health plans. On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with Lyn to discuss: Insights from Lyn’s move into the managed care side of health law, from her time with the DMHC to her role as VP of Legal Services for agilon health agilon health’s unique platform and physician partnership model, and differs from traditional physician practice management How to overcome the challenges of supporting and expanding independent physician practices Key differences between the new direct contracting model and a traditional Medicare accountable care organization The impact of agilon’s model on physician workflow and patient care, and the significant benefit of value-based care Additional Resources:
McDermott+Consulting Vice President has nearly 25 years of experience in the health policy arena, having spent more than two decades as a staff member on Capitol Hill before moving into health policy consulting. On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with Rodney to discuss: Insights from Rodney’s time on Capitol Hill, from the Republican takeover of Congress in 1994 to the Obama administration in the 2010s Lessons learned from the successes and failures of both parties on big health policy matters The value of listening, political shifts in the US and the state of health policymaking in Congress today Key health policy priorities for the current administration and Congress Insights into reconciliation efforts and critical policy changes with telehealth and Medicare Additional Resources:
McDermott+Consulting Vice President Debbie Curtis served as a chief of staff to a member of Congress and a member of the professional staff on the House Committee on Ways & Means, as well as a deputy director of the DC Health Benefit Exchange. On this episode of In the Trenches, McDermott partner and program host Brian Stimson sits down with Debbie to discuss: Debbie’s experience with health policy on Capitol Hill Lessons learned from growing the DC Health Exchange Debbie’s perspective on the Administration’s prioritization of health equity and approaches to Medicare and Medicaid. Insights into the potential post-pandemic public healthcare priorities of the Administration and the Congress, including hospital structures and telehealth Key issues for today’s public health system Additional Resources:
As corporate directorship increases in complexity, the ability of directors to fully engage with the board agenda and to be an effective partner to management are two of the most critical corporate governance issues. In this environment, the ability of directors to be “certified” as to their competency to serve is attracting greater interest. To review what board members need to know about director certification and how the National Association of Corporate Directors (NACD) works to support the profession of directorship, is joined by , COO, General Counsel, and Corporate Secretary for the NACD. She also leads NACD’s Director Certification Program and joins us to discuss the process and importance of engagement certification, including: · The driving focus behind and key elements of the NACD director qualification · How NACD works to support new directors and expand the pool of qualified director candidates · An overview of the certification process from start to finish · The future of director certification in light of governance oversight expectations Additional Resources:
In this unusual post-pandemic recovery period, the economic signals on which business leaders and policymakers rely to inform their decisions are going haywire. To help answer the difficult economic questions facing healthcare officers, executives and advisors, is joined by , CEO of Challenger, Gray & Christmas, a global outplacement firm, to discuss the board’s top post-pandemic economic challenges, including: 4 challenging economic factors impacting healthcare board members and trustees Insights into job participation rate and unemployment rates The current inflationary trend and its impact on healthcare organizations Focused work of key committees including finance, human capital, and strategic planning Trends in CEO turnover that search and succession committees need to watch Additional Resources:
As the United States Attorney for the District of Hawaii, McDermott partner led a team responsible for representing the United States in a wide array of criminal and civil litigation. On this episode of In the Trenches, he sits down with host to discuss: His military experience and the impact it had on his approach to leadership The importance of relationship building with the law enforcement community Leading the US Attorney’s Office in Hawaii, including his work on national security and drug trafficking matters Insights for general counsels on heightened enforcement activity from COVID-19, including government fraud and cybersecurity The impact of corporate culture on compliance, responding to investigations and federal enforcement Additional Resources:
Board responsibilities for COVD-19 related concerns aren’t over yet—not by a longshot. On this episode of the Governing Health podcast, and special guest , President of Orlikoff & Associates, Inc. and a national advisor on governance and leadership to the American Hospital Association, discuss: COVID-19 focus while pursuing business resiliency Insights into the board’s role in preparing for potential new disease profiles Governance implications of mask-wearing and vaccination implementation Bracing for potential post-COVID-19 hospital readmissions The board’s public profile on public health matters Insights into the composition of the post-pandemic health system and hospital boards The most persistent long-term and acute implications of COVID-19 on society and healthcare systems Proactive steps that boards need to take when preparing for potential future surges and booster vaccinations Additional Resources:
The President’s recently-released budget presents policy and business questions for every industry within the health sector. To help make sense of the potential impact on the health sector, today’s episode of In the Trenches zeroes in on the proposals in the budget related to the Department of Health and Human Services (HHS). , former Acting Assistant Secretary for Financial Resources at HHS and , Vice President of , join host to discuss: Presidential budget proposals and federal budgeting during transitions generally HHS programs that may benefit from the proposed spending increase in the budget Business opportunities and timelines related to the Advanced Research Projects Agency for Health (ARPA-H) accelerator initiative at the National Institute of Health Biden campaign promises reflected in the budget, including cancer research and civil rights issues Potential impact of equity policies on government grants and contracts Treatment of Medicare, Medicare Advantage, Medicaid, and Exchange plans in the budget Jen and Mara’s insights into probable year-end actions and impending bills Additional Resources:
Conversation with a "Lawyer's Lawyer" on Appellate and Executive Branch Advocacy , Associate Chief Counsel at the , is the quintessential lawyer’s lawyer, having served as a Supreme Court Clerk, Associate Counsel to the President, and Deputy Associate Attorney General. On this episode of In the Trenches, , McDermott partner and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services (HHS), sits down with Jenn to discuss her perspectives on: Supreme Court and appellate advocacy The roles of White House Counsel’s Office, the US Department of Justice and federal agencies in rulemakings and administrative litigation The DOJ litigating components and their roles, institutional interests and approaches to litigation Key issues in Administrative Procedure Act litigation for American businesses Hot class action and mass action issues, including no-injury class actions, predominance and mass arbitrations
McDermott partner Julian André served as a federal criminal fraud prosecutor for six years in one of the busiest and most dynamic jurisdictions in the United States: the Central District of California. His service spanned the COVID-19 pandemic when the U.S. Department of Justice was ramping up efforts to police frauds on COVID-19 relief programs. On this episode of In the Trenches, Brian Stimson, McDermott partner and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services (HHS), explores the following topics with Julian: > Increased enforcement activity and fraud prosecution following the implementation of COVID-19-related government programs > Julian’s experience in the Central District, including his leadership and work on securities and education fraud enforcement > Julian’s perspectives on healthcare fraud enforcement in the Central District of California and other jurisdictions > Insights and words of wisdom for general counsels navigating investigations or litigations in the Central District
McDermott partner Julian André served as a federal criminal fraud prosecutor for six years in one of the busiest and most dynamic jurisdictions in the United States: the Central District of California. His service spanned the COVID-19 pandemic when the U.S. Department of Justice was ramping up efforts to police frauds on COVID-19 relief programs. On this episode of In the Trenches, Brian Stimson, McDermott partner and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services (HHS), explores the following topics with Julian:
Increased enforcement activity and fraud prosecution following the implementation of COVID-19-related government programs
Julian’s experience in the Central District, including his leadership and work on securities and education fraud enforcement
Julian’s perspectives on healthcare fraud enforcement in the Central District of California and other jurisdictions
Insights and words of wisdom for general counsels navigating investigations or litigations in the Central District
Driving the Deal Podcast: Restructuring and Bankruptcy Considerations 2020 brought a global liquidity crunch impacting many industries, including healthcare. In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling speaks with colleague Felicia Perlman, Partner and Global Co-Head of McDermott’s Restructuring and Insolvency Practice Group. They discuss restructuring and bankruptcy trends, including the impacts to private equity and forecasts for the healthcare industry moving forward. Specific topics include:
Restructuring trends that are unique to the healthcare industry Strategic guidance for private equity investors when preparing for a potential restructuring Industries prime for restructuring and their impact on healthcare
A revitalized focus on antitrust in healthcare has increased healthcare companies’ concerns about their compliance status. On this episode of In the Trenches, , McDermott partner and former Principal Deputy Counsel for the US Department of Health and Human Services, and Antitrust partner , former prosecutor in the Department of Justice Antitrust Division, for an overview of healthcare antitrust enforcement issues and proactive steps companies need to take in order to remain compliant. Brian and Justin discuss: The focus of DOJ’s Procurement Collusion Strike Force (PCSF) and defining the “red flags of collusion” DOJ’s use of data analytics The top two industries facing increased antitrust enforcement attention, cases to watch and practical steps for companies under investigation The role of a computer hacking and intellectual property (CHIP) prosecutor The value of experienced defense counsel in antitrust investigations Recommended steps for healthcare organizations to assess their procurement protocols and other compliance programs Additional Resources:
In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Neil Krauter, National Practice Leader of Private Equity at Risk Strategies and Founder of Krauter & Company. With a wealth of experience in private equity insurance, Neil explains how private equity funds' needs have changed and addresses current trends in the space, including:
The evolving role of rep and warranty insurance in private equity investments Insurance dynamics and issues in the rapidly changing SPAC deal space Key insights into due diligence, billing and coding
On this episode of In the Trenches, , McDermott partner and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services (HHS), is joined by , Vice President of McDermott+Consulting and guest , former Senior Counselor in the Office of Management and Budget (OMB) for a conversation on rulemaking processes, the Biden administration's expected approach on health policy and more. Satya, Brian and Mara discuss: The roles of OMB, the Office of Information and Regulatory Affairs (OIRA) and the Department of Health and Human Services (HHS) in the rulemaking process Approaches and top tips for effectively engaging with OIRA and OMB Real-world examples of navigating interagency communication during the rulemaking process The Biden administration's approach to executive orders in early days of his presidency
On this episode of In the Trenches, , McDermott partner and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services (HHS), sits down with McDermott partners and , two former Department of Justice (DOJ) prosecutors with decades of combined experience trying cases and conducting investigations across the US and in collaboration with international enforcement agencies. Brian, Ben and Carlos look back on the valuable experience they gained and top achievements while with the federal government and look ahead at potential enforcement challenges and proactive steps companies should take when engaging with DOJ, including: Company and individual actions that can raise enforcement risks Insights into collaborations between civil and criminal prosecutors Understanding settlements with DOJ, the UK Serious Fraud Office (SFO) and other international law departments Foreign Corrupt Practices Act (FCPA) risk areas facing pharma companies Addressing company and country cultures when establishing compliance protocols to mitigate enforcement risk Telehealth fraud and other high priority areas of enforcement for the DOJ today
In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling speaks with Barry Freeman, Managing Director and Co-Head of Healthcare at Lincoln International, about current trends and topics surrounding the evolution of healthcare and its impact on private equity. They discuss:
A shifting mindset surrounding deals in the payor market Key questions private equity investors want answered before investing in healthcare Growth trends in government payor plans and their impact on providers Investor insights into the home healthcare and telehealth spaces
In this episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Cheairs Porter and Geoff Smith, Managing Directors at Harris Williams, to discuss key topics surrounding mergers and valuations in the private equity space, including:
Key characteristics of various competitive fund managers and non-traditional private equity funds Merging and scaling practice management assets and upcoming platform combination opportunities Steps to running a successful auction process from a seller’s perspective Valuation predictions for strong healthcare businesses in 2021
In the latest episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Jeff Woods, Co-Head of Healthcare at EY-Parthenon, to discuss macro trends that are impacting private equity investments in healthcare including:
The impact of deferred healthcare spending on new private equity deal activity Investment opportunities in urgent care, healthcare IT and surgical specialties Key considerations when investing capital in hospitals Trending investment activity in healthcare and technology
In the latest episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Tricia Lebo, Managing Director at Citizens Bank, to discuss opportunities that could spur private equity deals in healthcare. The topics they cover include:
The current state of the debt markets and their impact on PE deal activity Investing opportunities arising from the growth in home medical equipment Other healthcare subsectors that are seeing deal activity pick up
In the third and final episode of our series on public hospital M&A, we discuss key regulatory considerations when executing public hospital M&A and planning for post-transaction success. McDermott partners Emily Cook and Megan Rooney are joined by Rex Burgdorfer, managing director at Juniper Advisory to discuss:
Key regulatory approvals that hospitals must anticipate and address Public and government hospital considerations regarding successful 340B participation, including DSH percentage thresholds The significance of critical access hospital status to acquirers and steps hospitals can take to maintain this designation and receive the same benefits as larger systems Steps hospitals can take to drive quality and financial agreements and promote post-transaction success The importance of effectively communicating with employees before dealmaking and the during the transition period
Healthcare payors face many potential changes in the coming year, all of which will impact private equity firms’ outlook on the sector. From federal initiatives to growth in value-based care, 2021 promises to bring significant challenges and opportunities.
In the second episode of the Collaborative Transformation: Driving the Deal series, McDermott Partner Krist Werling is joined by Frank Martin, Vice President of the Managed Care division at Farragut Square Group. They discuss why payor changes impact private equity, covering:
What investors can expect from the Biden administration for future expansion of Affordable Care Act plans How payors will likely approach value-based care in 2021 The potential for telehealth to create major disruptions with payors in the provider market Potential changes to the production of critical medical equipment and Medicare drug prices
Despite the pandemic's impact, the volume of healthcare private equity transactions accelerated in the latter half of 2020. Now in a new year with a new administration, investors should expect both new opportunities and challenges to emerge in the healthcare sector.
To help navigate the evolving landscape, we're dedicating a series of podcast episodes to healthcare private equity. Hosted by McDermott Partner, look for new episodes as part of the Collaborative Transformation: Driving the Deal feed.
In this first installment, Krist talks with Brian Fortune, Senior Director at Farragut Square Group, about the top priorities private equity investors should focus on under the Biden administration, including:
How key government committees could shape healthcare legislation and the resulting impact on private equity investment Sectors that would most benefit from increased Medicaid support Changes to the proposed 2021 Medicare physician fee schedule Sectors offering private equity investors the biggest upside under the Biden administration Political power and potential pressure that accompanies Medicare Advantage
The rollout of the COVID-19 vaccine to select healthcare providers, employees and patients raises a number of unprecedented questions for hospitals and health systems as both healthcare providers and employers. While some hospitals have been selected as the first to receive and issue the vaccines, others are left wondering how they can protect their employees and high-risk patients until the vaccines are more widely available. In this discussion, healthcare, employment and health policy leaders from McDermott Will & Emery and McDermott+Consulting come together to explore the novel issues that healthcare providers should examine as we navigate the vaccination process.
This episode is available as a video. Watch it here: https://coronavirus.mwe.com/the-vaccine-understanding-whats-next/
Reducing the Burden - Noteworthy Changes to the Stark Law by McDermott Health Podcast Channel
Sprint Ready: Reducing the Burden - Noteworthy Changes to the Anti-Kickback Statute Regulations by McDermott Health Podcast Channel
Sprint Ready: Making Sense of the Stark Law and AKS Final Rules - Top Changes You Need to Know by McDermott Health Podcast Channel
COVID-19 led to major policy changes impacting how healthcare is delivered and reimbursed but only some of these new policies will endure in coming years. On this episode of the After the Curve Podcast, we discuss how the regulatory landscape and enforcement priorities may shift in both the short and long term as we transition to the post-COVID-19 era. McDermott’s Chief Marketing Officer Leslie Tullio is joined by Monica Wallace and Emily Jane Cook to discuss topics surrounding pandemic-induced regulatory and enforcement changes.
COVID-19 led to major policy changes impacting how healthcare is delivered and reimbursed but only some of these new policies will endure in the coming years. On this episode of the After the Curve Podcast, we discuss how provider organizations can innovate their business models and care delivery to adapt and thrive in a post-COVID-19 world. McDermott’s Chief Marketing Officer Leslie Tullio is joined by Sandy DiVarco and Emily Cook to discuss topics surrounding the impact of the pandemic on healthcare provider organizations.
COVID-19 has catalyzed significant changes in the patterns of healthcare delivery, with the potential for long-lasting effects on payors as a result. On this episode of the After the Curve podcast, we discuss how the COVID-19 pandemic may shift the healthcare coverage and payment landscape as well as how it may boost integration among payors and providers. McDermott’s Chief Marketing Officer Leslie Tullio is joined by and to discuss relevant topics for both payers and the healthcare industry more broadly, including: How COVID-19 is changing healthcare utilization patterns in the US and the impact of that disruption on insurers The reaction from health plans to the financial impact of COVID-19 on providers The impact of telehealth and regulatory waivers at the state and federal levels on the payor market Top lessons that payors have learned from the pandemic and subsequent next steps Opportunities for healthcare leaders to synthesize where we are today Key takeaways for payors moving forward from the pandemic Additional Resources:
The lasting impact of COVID-19 on healthcare transactions is multifaceted and has rapidly altered the trajectory of the dealmaking landscape as well as business collaborations. On this episode of the After the Curve podcast, we discuss how the COVID-19 pandemic is affecting healthcare transactions today, as well as the outlook for the healthcare deal landscape post-COVID-19. McDermott’s Chief Marketing Officer Leslie Tullio is joined by Jed Spielman and Kevin Miller to discuss topics surrounding the impact of the pandemic on healthcare transactions, including:
The sectors of the healthcare industries that are most likely to experience a surge in deal volumes and why
COVID-19-induced programs that have altered the way healthcare transactions are getting done
Which transformational aspects of transaction protocol are most likely to carry into the post-COVID-19 future
Insights from the transactions perspective and a look at the most promising upcoming collaborations
Advice for dealmakers and healthcare leaders who are looking to effectively adjust their portfolios in a post-COVID-19 environment
In this time of crisis, the life science industry has demonstrated remarkable speed, innovation and resilience. In this episode of the After the Curve podcast, our life sciences partners join us to discuss the most promising areas of drug discovery and device development that are emerging from the pandemic and the outlook for the industry in a post-COVID-19 world. McDermott’s Chief Marketing Officer, Leslie Tullio, is joined by Stephen Bernstein and Kristian Werling to discuss key topics impacting the life sciences industry today.
On this episode of the After the Curve podcast, Eric Zimmerman, Mara McDermott and Jessica Roth from McDermott+Consulting join us to discuss how the pandemic has changed the conversation leading up to the November presidential election and how key policy issues will evolve in the months and years to come.
COVID-19 has demanded a rapid shift in the world of telehealth and digital health, resulting in a global embracing of a telehealth and digital health system that is not yet fully developed. On this episode of the McDermott Health podcast, our digital health partners have joined to discuss the future of telehealth and use of digital tools to speed up care delivery and to improve outcomes in the wake of COVID-19, as well as the vital role of data readiness in reshaping the healthcare system. McDermott’s Chief Marketing Officer Leslie Tullio is joined by partners Stephen Bernstein and Lisa Mazur to examine current trends and potential changes to both telehealth as well as the broader digital health landscape.
Driving the Deal: Public Hospital M&A and Stakeholder Buy-In by McDermott Health Podcast Channel
The COVID-19 health law briefing you need for the week of June 8. This episode covers:
The Department of Health and Human Service’s announcement of more targeted Provider Relief Funds Further guidance from CMS on reopening healthcare facilities New opportunities for stakeholders to help shape healthcare delivery during and after the pandemic
The COVID-19 health law briefing you need for the week of June 1. This episode covers:
Provider Relief Fund update, including the bipartisan letter to the Department of Health and Human Services (HHS) requesting expedited distribution to healthcare provider and recent updates to the HHS FAQs on the Provider Relief Fund Centers for Medicare and Medicare Services (CMS) Innovation Model Flexibilities update The CMS Nursing Home Report, the first official tally of infections and deaths in nursing facilities due to COVID-19 in nursing facilities
Public hospitals have a uniquely open relationship to the communities they serve, which invites a level of transparency as they consider potential mergers and acquisitions. So what kind of M&A deal activity options are out there for public hospitals dealing with financial pressures, and how can parties navigate regulatory, financial and public opinion to get the deal done? In this episode of Collaborative Transformation podcast series, Rex Burgdorfer, managing director at Juniper Advisory, joins McDermott partner Megan Rooney to discuss:
The major trends driving public hospital M&A How M&A can strengthen hospitals financially and the regulatory and external challenges contributing to financial pressures Unique regulatory and financial challenges faced by public hospitals Benefits of privatization in the hospital industry The role public sentiment can play in public hospital transactions
The COIVD-19 health law briefing you need for the week of May 25. This episode covers:
Strategic plan from the Department of Health and Human Services Office of Inspector General Provider Relief Fund FAQs Republican and Democrat health information privacy bills White paper on healthcare coverage expansion during the pandemic HHS’s outline on testing capacity goals HRSA funds awarded to tribal health organizations
The COVID-19 health law briefing you need for the week of May 18, 2020. This episode covers:
HEROES Act stimulus package and notable changes that health stakeholders should watch from the bill President Trump's executive order to examine which regulation suspensions should be made permanent HHS distributes provider relief funds to nursing homes Additional funding dispersed for COVID-19 testing
May 15 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
May 8 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
May 1 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
April 24 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
April 17 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
April 10 Friday Newsflash | Coronavirus Health Law Briefing by McDermott Health Podcast Channel
The healthcare industry is facing significant disruption from new market entrants and technology innovations that have the potential to improve how healthcare is delivered. But how do you tell which innovative technologies and ventures will have a sustained and positive impact, and which are just noise? In this episode of the Collaborative Transformation podcast series, Lucia Savage, chief privacy and regulatory officer at Omada Health, joins McDermott partner Jennifer S. Geetter to discuss:
What it takes for disruption to be truly constructive in today’s dynamic market The rise of mobile healthcare delivery and patient engagement, driven by technological advances and consumer expectations The limits of the HIPAA regulatory framework and current reimbursement rules as they relate to digital health technologies Tips for tapping into the growing digital health innovation community through strategic investment
Healthcare is facing a time of transformation as regulators, providers and other stakeholders take action to improve care coordination and increase the use of technology to deliver care. Hospital and health system innovation centers are increasingly acting as the catalyst to fuel growth and expansion through technology and data. In this episode of the Collaborative Transformation podcast series, McDermott partners Kerrin Slattery and Krist Werling discuss:
Opportunities for innovation centers and other collaborative arrangements in healthcare Top regulatory and compliance challenges innovators face and ways to navigate them Organizational and cultural issues for healthcare leaders to consider when making innovation a strategic priority Investment structures and unique due diligence concerns to address when designing or investing in innovative deals Key considerations when executing cross-border transactions in healthcare and life sciences
On this this episode of the Collaborative Transformation podcast series, European life sciences lawyers Emmanuelle Trombe (Paris) and Gary Howes (London) discuss top areas for global collaboration in the life sciences space, the role of technology companies and other new collaboration partners, hurdles to overcome when structuring deals across industries, navigating international data regulations, including GDPR and considerations for executing successful biotech and pharma deals.
For more information on Collaborative Transformations, visit us at mwe.com/collaborativetransformation
In an environment of change and uncertainty, health and life sciences organizations are embracing new ways of engaging and working with partners from inside and outside the health sector through Collaborative Transformations. In this podcast, McDermott's health and life sciences partners Kerrin Slattery, Dale Van Demark and Charlie Buck discuss how the top market players are working to drive and deliver game-changing innovations and shape the future of health care through impactful deal making. (499 characters)
Listen to McDermott’s Digital Health Thought Leaders Share Their Perspectives on the proliferation of digital devices and what it means to the marketplace today.